854 results on '"Schaeverbeke, Thierry"'
Search Results
52. Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE
53. De la discrimination du soi à la perception du « Danger » : l’évolution des grands concepts immunologiques
54. Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexate
55. Méta-analyse sur l’efficacité clinique et radiographique des biothérapies dans la polyarthrite rhumatoïde chez des patients naïfs ou en réponse inadéquate au méthotrexate
56. When and where does rheumatoid arthritis begin?
57. Où et quand commence la polyarthrite rhumatoïde ?
58. Abatacept therapy and safety management
59. Potential Role of Mycoplasma hominis in Interleukin (IL)-17-Producing CD4⁺ T-Cell Generation Via Induction of IL-23 Secretion by Human Dendritic Cells
60. Rheumatologic and neurological events in an elderly patient with tricho-rhino-phalangeal syndrome type I
61. TNF alpha antagonist therapy and safety monitoring
62. Optimizing methotrexate therapy in rheumatoid arthritis: A systematic literature review
63. Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review
64. Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus
65. Intérêt de la triple association méthotrexate, salazopyrine et hydroxychloroquine dans la polyarthrite rhumatoïde : analyse systématique de la littérature
66. Valeur discriminante des items des critères ACR/EULAR 2010 : analyse systématique de la littérature
67. Incidence de la tuberculose chez les patients atteints de polyarthrite rhumatoïde. Revue systématique de la littérature
68. Implication des Toll-like récepteurs dans les maladies auto-immunes : exemple du lupus érythémateux systémique
69. Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation
70. Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
71. Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practice
72. Role for interferon regulatory factors in autoimmunity
73. Indications of glucocorticoids in early arthritis and rheumatoid arthritis: Recommendations for clinical practice based on data from the literature and expert opinion
74. Use of glucocorticoids in rheumatoid arthritis – Pratical modalities of glucocorticoid therapy: Recommendations for clinical practice based on data from the literature and expert opinion
75. Tocilizumab: Therapy and safety management
76. Implication de la famille des facteurs de transcription IRF dans l’auto-immunité
77. The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis
78. TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
79. Diagnosis of peripheral psoriatic arthritis: Recommendations for clinical practice based on data from the literature and experts opinion
80. Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: Development of recommendations for clinical practice based on published evidence and expert opinion
81. Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: Development of recommendations for clinical practice based on data from the literature and experts opinion
82. Association of Anti–Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis
83. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
84. Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene
85. Abatacept therapy and safety management
86. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
87. SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis
88. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis
89. Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort
90. Sources of Information on Lymphoma Associated with Anti-Tumour Necrosis Factor Agents: Comparison of Published Case Reports and Cases Reported to the French Pharmacovigilance System
91. Interleukin‐1β–Activated Microvascular Endothelial Cells Promote DC‐SIGN–Positive Alternatively Activated Macrophages as a Mechanism of Skin Fibrosis in Systemic Sclerosis.
92. Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study
93. Correspondence on ‘Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting’
94. Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients
95. Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments
96. La cohorte Espoir : un suivi de dix ans des arthrites débutantes en France. Méthodologie et caractéristiques initiales des 813 patients inclus
97. GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
98. Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)
99. Tolerance of Rituximab in Patients with a History of Cancer: Data From the Registry Air.: 1313
100. Early Neutropenia Is Associated with Clinical Response in Patients Receiving Tocilizumab in Rheumatoid Arthritis.: 1302
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.